In a paper published in the Journal of Immunology the team, led by LSTM's Professor Richard Pleass, revealed that by engineering a part of an antibody they can target the viral proteins that allow flu to mutate and become deadly to humans.
This newly-engineered antibodies are more than 100 times effective at killing cancer cells than the ones that have been clinical trialled.
Pune based Serum Institute of India, a part of Cyrus Poonawalla Group and the world's largest manufacturer of vaccines announced today.
Universal vaccine against influenza possible?
In a paper published in the Journal of Immunology the team, led by LSTM's Professor Richard Pleass, revealed that by engineering a part of an antibody they can target the viral proteins that allow flu to mutate and become deadly to humans.
This newly-engineered antibodies are more than 100 times effective at killing cancer cells than the ones that have been clinical trialled.
Pune based Serum Institute of India, a part of Cyrus Poonawalla Group and the world's largest manufacturer of vaccines announced today.
Universal vaccine against influenza possible?
